Nephrotoxicity pp 325-330 | Cite as

Intracellular Localization of Cyclosporin A in the Rat Kidney

  • Miloslav Dobrota
  • Julian R. Louis


Cyclosporin A (CyA), a most potent and clinically useful immuno-suppres-sive agent, also produces a number of side-effects in man and experimental animals. Nephrotoxicity, characterised by the formation of numerous large vacuoles in the straight proximal tubules in the corticomedullary region or the S3 (P3) segment of the nephron (1), is the most notable side effect of CyA. There are indications that the S3 region may also accumulate the greatest proportion of CyA (2). The biochemical changes associated with the nephrotoxicity are consistent with tubular damage and include elevated urinary excretion of lysosomal and brush border enzymes (3). The hetero-geneous range of vacuoles appear to be of lysosomal, mitochondrial and possibly of endoplasmic reticulum origin. However, the positive localiz-ation of acid phosphatase within many of the vacuoles (4) suggest that the majority might be of lysosomal origin. What remains unknown is whether these vacuoles form as a result of accumulation of cyclosporin or as an indirect effect of more complex secondary factors. The aim of the study described here was to investigate the intracellular localization of CyA in the kidney and to determine whether the vacuoles accumulate and contain CyA.


Sucrose Sedimentation Fractionation Cyclosporin Cytosol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    M.J. Mihatsch., B. Ryffel, M. Hermle., F.P. Brunner and G. Thiel (1986). Morphology of cyclosporin nephrotoxicity in the rat. Clin. Nephrol. 25 (Suppl 1): 52–58.Google Scholar
  2. 2.
    B. Ryffel., J. Wilson., R. Maurer., F. Gudat and Mihatsch. (1986). Problems of cyclosporine localisation in the renal tissue. Clin. Nephrol25 (Suppl 1): 534–536.Google Scholar
  3. 3.
    P.H. Whiting., A.W. Thompson and Simpson, J.G. (1986). Cyclosporine and renal enzyme excretion. Clin. Nephrol. 25 (Suppl 1): 5100–5104.Google Scholar
  4. 4.
    G.A. Verpooten., I. Wybo., V.M. Pattyn., P.G. Hendrix., R.A. Guiliano., E.J. Nouwen, E.J., F. Roels and M.E. DeBroe (1986). Cyclosporin nephrotoxicity: Comparative cytochemical study of rat kidney and human allograft biopsies. Clin. Nephrol. 25 (Suppl 1): 518–522.Google Scholar
  5. 5.
    K.J. Andersen., H.J. Haga and M. Dobrota. (1987). Lysosomes of the renal cortex: Heterogeneity and role in protein handling, Kid Internat. 31: 886–897.CrossRefGoogle Scholar
  6. 6.
    F.J. Gerkens., S.B. Bhagwandeen., P.J. Dosen. and A.J. Smith, (1984). The effect of salt intake on cyclosporine–induced impairment of renal function in rats. Transplantation, 38: 412–423.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • Miloslav Dobrota
    • 1
  • Julian R. Louis
    • 1
  1. 1.Robens Institute of Industrial and Environmental Health and SafetyUniversity of SurreyGuildford, SurreyUK

Personalised recommendations